Bone morphogenetic protein use in the cervical spine: questions about safety and effectiveness

COMMENTARY ON Goode AP, Richardson WJ, Schectman RM, Carey TS. Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions. Spine J 2014;14:2051-9 ( in this issue ).